Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Urinary retention, neurological disease or neonatal exposure
Inability to void, sacral radiculitis, meningism, encephalopathy, disseminated lesions, severe immunosuppression or vesicles and sepsis in a neonate require urgent hospital treatment.
Action: Use ABCDE, obtain lesion and blood or CSF specimens where appropriate, begin intravenous aciclovir without waiting for confirmation in severe or neonatal disease, provide bladder and pain support and involve infection, neurology, urology, paediatrics or maternity.
Synopsis
Recognise primary and recurrent genital herpes, confirm infection from fresh lesions, relieve pain, use time-sensitive antivirals and manage pregnancy and neonatal exposure safely.
Primary genital herpes may cause multiple painful vesicles or shallow ulcers, dysuria, tender nodes, fever and profound malaise.
Recurrent disease is usually shorter and milder, often preceded by tingling or burning in a similar dermatomal area.
Swab the base of a fresh vesicle or ulcer for HSV-1 and HSV-2 NAAT; blood serology does not confirm the cause of an active ulcer.
Key red flags
Severe pain with inability to pass urine may require admission, analgesia and temporary catheterisation.
Sacral radiculitis
Urinary retention, constipation, perineal sensory change or leg symptoms during herpes suggests autonomic and nerve-root involvement.
Investigation priorities
01
Lesion HSV NAATFirst step
Confirm herpes and distinguish HSV-1 from HSV-2 using material from a fresh vesicle or ulcer base.
Management branches
FIRSTTreat the first episode promptly
Painful genital vesicles or ulcers began within five days or new lesions continue to appear.
Swab a fresh lesion for typed HSV NAAT and obtain syphilis, HIV and site-specific STI testing.
Start aciclovir 400 mg orally three times daily for five days without waiting for the result.
Key medicines
Aciclovir for first episodeGive 400 mg orally three times daily for five days, starting within five days of onset or while new lesions continue to appear.
Aciclovir episodic recurrenceGive 800 mg orally three times daily for two days, begun during prodrome or immediately when recurrent lesions appear.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.